Minerva Neurosciences, Inc: Minerva Neurosciences Reports Fi

Company to Host Conference Call Today at 8:30 a.m. ETBURLINGTON, Mass., March 08, 2023(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central

Related Keywords

Dennis Riedl , Helen Shik , Remy Luthringer , Frederick Ahlholm , Minerva Neurosciences , Shik Communications , Company To Host Conference Call , Minerva Neurosciences Inc , Nasdaq , Host Conference Call Today , Executive Chairman , Chief Executive Officer , Year End Financial , Federal Food Drug , Cosmetic Act , Call Information , Private Securities Litigation Reform Act , Term Liabilities , Months Ended December , Aminerva , Neurosciences , Reports , Iscal , Ear , 022 , Fourth , Quarter , Financial , Results , Business , Updates ,